A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis
Clinical trial NCT05807529 · UNKNOWN
Trial details
- NCT number
- NCT05807529
- Sponsor
- Orient Europharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-03
- Primary completion
- 2024-12-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.